COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations

Overview of attention for article published in Nature Reviews Rheumatology, February 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#45 of 2,763)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 6 news outlets
blogs: 1 blog
twitter: 103 X users
facebook: 2 Facebook pages

reddit: 2 Redditors
guideline: 2 clinical guideline sources
podcasts: 1 podcast

Readers on

mendeley: 120 Mendeley

So far, Altmetric has seen 6 news stories from 6 outlets.

NEJM paper fills in details on ‘remarkable’ CAR-T result in autoimmune disease

Yahoo! Finance USA, 21 Feb 2024

A new research paper offers the most thorough look yet at a study that sparked the drug industry’s recent experimentation with…

NEJM paper fills in details on ‘remarkable’ CAR-T result in autoimmune disease

BioPharma Dive, 21 Feb 2024

A new research paper offers the most thorough look yet at a study that sparked the drug industry’s recent experimentation with…

Impfstoff unzureichender Schutz gegen Omicron

Nachrichten Welt, 07 Aug 2022

Eine neue Studie hat herausgefunden, dass mRNA-Impfstoffe (die von Moderna und Pfizer) nicht genügend Antikörper erzeugen, um…

COVID and ARD: Vaccine insufficient protection against Omicron

UK Time News, 07 Aug 2022

A new study has found that mRNA vaccines (those from Moderna and Pfizer) don’t make enough antibodies to protect against the…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 2 additional news stories.